Q32 Bio (QTTB) Shares Outstanding (Diluted Average) (2021 - 2026)

Q32 Bio (QTTB) recorded quarterly Shares Outstanding (Diluted Average) of $14.1 million in Q1 2026, up 14.46% quarter-over-quarter from $12.3 million in Q4 2025, and up 15.56% on a YoY basis from $12.2 million in Q1 2025.

Q32 Bio (QTTB) Shares Outstanding (Diluted Average) (2021 - 2026) Analysis & Trends

Q32 Bio's Shares Outstanding (Diluted Average) history runs 6 years deep, the most recent figure standing at $14.1 million for Q1 2026.

  • In Q1 2026, Shares Outstanding (Diluted Average) rose 15.56% year-over-year to $14.1 million; the TTM figure through Mar 2026 stood at $14.1 million (up 15.56% YoY), while the FY2025 annual figure was $12.3 million, up 27.51% from the prior year.
  • Shares Outstanding (Diluted Average) was $14.1 million for Q1 2026 at Q32 Bio, up from $12.3 million in the prior quarter.
  • In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $57.9 million in Q1 2022 to a low of $344623.0 in Q1 2023.
  • Historically, Shares Outstanding (Diluted Average) has averaged $19.3 million across 5 years, with a median of $12.2 million in 2025.
  • The sharpest annual moves came in 2023 and 2024: Shares Outstanding (Diluted Average) sank 99.4% in 2023, then soared 3338.63% in 2024.
  • A 5-year view of Shares Outstanding (Diluted Average) shows it stood at $57.4 million in 2022, then tumbled by 99.39% to $349060.0 in 2023, then surged by 2666.77% to $9.7 million in 2024, then increased by 27.51% to $12.3 million in 2025, then grew by 14.46% to $14.1 million in 2026.
  • The last three Shares Outstanding (Diluted Average) figures came in at $14.1 million (Q1 2026), $12.3 million (Q4 2025), and $12.2 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares (Diluted Avg.) (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 4,489.46 Bn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 810.00
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 118.76 Bn
7 Psyence Biomedical 212.16 Bn 212.16 Bn - 1.48 Bn
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 256.30 Mn
9 Abivax 91.96 Bn 91.96 Bn - 92.44 Mn
10 Q32 Bio 167.59 Mn 116.84 Mn - 14.10 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 14.10 Mn
Dec 31, 2025 12.31 Mn
Sep 30, 2025 12.21 Mn
Jun 30, 2025 12.20 Mn
Mar 31, 2025 12.20 Mn
Dec 31, 2024 9.66 Mn
Sep 30, 2024 8.81 Mn
Jun 30, 2024 11.96 Mn
Mar 31, 2024 2.33 Mn
Dec 31, 2023 349,060.00
Sep 30, 2023 346,288.00
Jun 30, 2023 347,936.00
Mar 31, 2023 344,623.00
Dec 31, 2022 57.40 Mn
Sep 30, 2022 57.45 Mn
Jun 30, 2022 57.39 Mn
Mar 31, 2022 57.88 Mn
Dec 31, 2021 55.28 Mn
Sep 30, 2021 57.11 Mn
Jun 30, 2021 53.43 Mn